Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
1don MSN
A hotel employee is facing possible indictment related to the sudden death of Liam Payne, after the One Direction alum ...
1don MSN
There appears to be evidence that a hotel employee sourced the drugs for Payne,” an insider, who asked to remain anonymous, ...
ABS-CBN News on MSN57m
PDEA: P49.82-B worth of illegal drugs seized under Marcos admin's anti-drug campaignPhilippine authorities have seized a total of P49.82-billion worth of illegal drugs under the Marcos administration's ...
1d
Rosie O’Donnell’s troubled daughter Chelsea Belle O’Donnell’s home in Wisconsin looked rundown and surrounded by trash in ...
Tablets labeled as dietary supplements for joint pain and arthritis are being recalled after the FDA found three undeclared ...
The family eventually found that medication. Later, two others Abby needed were hard to find. The Brays, like thousands of ...
11don MSN
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
An off-label clot-busting drug appears to work slightly better in treating stroke patients than an approved medication, a new ...
The Brighterside of News on MSN1d
New class of drugs target brain metabolism to treat Alzheimer’s patientsRecent research highlights the potential of targeting the brain’s metabolism to treat Alzheimer’s disease, a condition that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback